SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001730574-23-000003
Filing Date
2023-03-31
Accepted
2023-03-31 09:38:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 athanor13d.txt SC 13D 21513
2 jetpacksideletter.pdf SC 13D 169817
  Complete submission text file 0001730574-23-000003.txt   251781
Mailing Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019
Business Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019 646-813-2470
Athanor Capital, LP (Filed by) CIK: 0001730574 (see all company filings)

IRS No.: 320520630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92696 | Film No.: 23783716
SIC: 2836 Biological Products, (No Diagnostic Substances)